This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:—
We subscribe wholeheartedly to the "tendentious pronouncements" of Dr. Marcus R. Caro (A.M.A. Arch. Dermat. 80:793 [Dec.] 1959) regarding the epidermal changes associated with histiocytoma or dermatofibroma of the skin. We remarked in 1943 (Arch. Dermat & Syph. 47:498 [April] 1943) upon the hyperplastic epidermal changes we had observed in 27 of these lesions. In perhaps 200 more of them seen since then, we have continued to see such changes. We have never observed any changes consistent with basal-cell epithelioma, and we share Dr. Caro's skepticism regarding the view of Dr. Halpryn and Dr. Allen that this lesion may occur in as many as 8% of histiocytomas.Though we prefer to call these lesions histiocytomas or dermatofibromas, we have no quarrel with those who call them nodular subepidermal fibrosis. The term "sclerosing hemangiomas," however, seems to us wholly inappropriate. For a lesion to be a sclerosing hemangioma,
Arnold HL, Tilden IL. EPIDERMAL CHANGES ASSOCIATED WITH "SCLEROSING HEMANGIOMAS". AMA Arch Derm. 1960;82(1):108. doi:10.1001/archderm.1960.01580010114025
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.